| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
It is urgent to develop novel therapies for infants with perinatal hypoxic-ischemic encephalopathy (HIE). In the present project, we have performed basic experiments to develop a novel therapy with bone marrow mononuclear cells (BM-MNC), which is most ideal source of stem cells for the treatment against perinatal brain injuries. We evaluated the effect of administration of BM-MNC on perinatal HIE rat. We injected BM-MNC intravenously after hypoxic-ischemic insult. The injected BM-MNC was detected in the lung less than when we administered bone marrow mesenchymal stem cells. BM-MNC administration exerted anti-apoptotic effect, and tended to ameliorate learning impairment induced by HIE.
|
